Positive Case Report on Ohr Pharmaceutical’s Squalamine Presented at the 37th Annual Macula Society Meeting

[Marketwired] – Ohr Pharmaceutical , a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that a case report on the first patient treated in an ongoing … more

View todays social media effects on OHRP

View the latest stocks trending across Twitter. Click to view dashboard

See who Ohr is hiring next, click here to view